OVN 0.00% 2.0¢ oventus medical limited

Ann: Quarterly Business Review & Appendix 4C, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,935 Posts.
    lightbulb Created with Sketch. 149
    The cut down in the lab in lab program now, towards the tail end of the pandemic, tells us that the lab in lab program is a failure, imo.
    If it was viable the board would be moving towards getting more funding from by approaching investors with evidence that the funding will not be wasted.

    Instead we are getting restructuring costs for yet another shift in the business model, this time into online sales.

    The failure of the lab in lab model now suggests that the product itself is not marketable. Clearly very few centres have managed to sell more than a couple of units each month.
 
watchlist Created with Sketch. Add OVN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.